X4 Pharmaceuticals, Inc Quarterly Operating Lease, Payments in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
X4 Pharmaceuticals, Inc quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q3 2024.
  • X4 Pharmaceuticals, Inc Operating Lease, Payments for the quarter ending September 30, 2024 was $345K, unchanged year-over-year.
  • X4 Pharmaceuticals, Inc Operating Lease, Payments for the twelve months ending September 30, 2024 was $1.38M, a 0.36% increase year-over-year.
  • X4 Pharmaceuticals, Inc annual Operating Lease, Payments for 2023 was $1.39M, a 2.29% increase from 2022.
  • X4 Pharmaceuticals, Inc annual Operating Lease, Payments for 2022 was $1.35M, a 7.72% increase from 2021.
  • X4 Pharmaceuticals, Inc annual Operating Lease, Payments for 2021 was $1.26M, a 67.1% decline from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.38M $345K $0 0% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $1.38M $343K -$2K -0.58% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $1.38M $344K -$2K -0.58% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $1.39M $349K +$9K +2.65% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 $1.38M $345K +$11K +3.29% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $1.37M $345K +$7K +2.07% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $1.36M $346K +$4K +1.17% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $1.35M $340K $0 0% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 $1.35M $334K +$20K +6.37% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $1.33M $338K +$58K +20.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $1.28M $342K +$19K +5.88% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $1.26M $340K -$2.52M -88.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-21
Q3 2021 $3.77M $314K -$165K -34.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $3.94M $280K +$38K +15.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $3.9M $323K +$81K +33.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $3.82M $2.86M +$2.59M +950% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-21
Q3 2020 $1.24M $479K +$211K +78.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $1.02M $242K -$24K -9.02% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $1.05M $242K +$41K +20.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $1.01M $272K Oct 1, 2019 Dec 31, 2019 10-K 2022-03-17
Q3 2019 $268K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $266K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $201K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.